Skip to main content
SpringerLink
Log in

Effect of Escitalopram on Serum GDNF and BDNF Levels and 5-HT Level of Brain Tissue of Obsessive–Compulsive Disorder Rats

  • Original Research
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Abstract

The present study aims to discuss the effect of escitalopram in glial cell line-derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF) levels, and 5-Hydroxytryptamine (5-HT) in obsessive–compulsive disorder rats. A total of 42 rats were divided into three groups randomly: control group (n = 14), model group (n = 14) (obsessive–compulsive disorder group), and escitalopram group (n = 14) (model + obsessive–compulsive disorder group + escitalopram treatment). The open-field method was used to test the rat behavior, enzyme-linked immunosorbent assay (ELISA) was used to determine the serum GDNF and BDNF levels. In addition, Western blot was used to determine the brain tissue protein levels of GDNF and BDNF and high-performance liquid chromatography + electrochemistry method to determine the 5-HT level of brain tissue. Visiting place was changed, rotational frequency and fixed duration enhanced in escitalopram group compared to model group (P < 0.05). Besides, GDNF and BDNF levels of serum and brain tissue were decreased in model group and escitalopram group compared to control group (P < 0.05), while GDNF and BDNF levels of serum and brain tissue were increased in escitalopram group compared to model group (P < 0.05). Moreover, the 5-HT level of brain tissue in escitalopram group was higher than that in model group (P < 0.05). Escitalopram could increase GDNF and BDNF levels and 5-HT content in serum and brain tissue in obsessive–compulsive disorder rats, which contributes to a function on the treatment of obsessive–compulsive disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Bagheri A, Talei S, Hassanzadeh N, Mokhtari T, Akbari M, Malek F, Jameie SB, Sadeghi Y, Hassanzadeh G (2017) The neuroprotective effects of flaxseed oil supplementation on functional motor recovery in a model of ischemic brain stroke: upregulation of BDNF and GDNF. Acta Med Iran 55(12):785–792

    PubMed  Google Scholar 

  • Bergman J, Pashinian A, Weizman A, Poyurovsky M (2014) The beneficial effect of escitalopram on obsessive-compulsive-related musical hallucinations in elderly patients with hearing impairment: a case series. Int Clin Psychopharmacol 29(5):263–265

    Article  Google Scholar 

  • Çolak Sivri R, Bilgiç A, Kılınç İ (2018) Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder. Eur Child Adolesc Psychiatry 27(8):977–984

    Article  Google Scholar 

  • de Wolmarans W, Brand L, Stein DJ, Harvey BH (2013) Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessive-compulsive disorder (OCD): response to escitalopram treatment and basal serotonin transporter (SERT) density. Behav Brain Res 256:545–553

    Article  CAS  Google Scholar 

  • Eilam D, Golani I, Szechtman H (1989) D2-agonist quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements. Brain Res 490(2):255–267

    Article  CAS  Google Scholar 

  • Fontenelle LF, Barbosa IG, Luna JV, Rocha NP, Silva Miranda A, Teixeira AL (2012) Neurotrophic factors in obsessive-compulsive disorder. Psychiatry Res 199(3):195–200

    Article  CAS  Google Scholar 

  • Ghio L, Gotelli S, Cervetti A, Respino M, Natta W, Marcenaro M, Serafini G, Vaggi M, Amore M, Belvederi Murri M (2015) Duration of untreated depression influences clinical outcomes and disability. J Affect Disord 175:224–228

    Article  Google Scholar 

  • Goodman WK, Grice DE, Lapidus KA, Coffey BJ (2014) Obsessive-compulsive disorder. Psychiatr Clin North Am 37(3):257–267

    Article  Google Scholar 

  • Guo Y, Luo C, Tu G, Li C, Liu Y, Liu W, Lam Yung KK, Mo Z (2018) Rhynchophylline downregulates phosphorylated cAMP response element binding protein, nuclear receptor-related-1, and brain-derived neurotrophic factor expression in the hippocampus of ketamine-induced conditioned place preference rats. Pharmacogn Mag 14(53):81–86

    Article  CAS  Google Scholar 

  • Ho EV, Thompson SL, Katzka WR, Sharifi MF, Knowles JA, Dulawa SC (2016) Clinically effective OCD treatment prevents 5-HT1B receptor-induced repetitive behavior and striatal activation. Psychopharmacology 233(1):57–70

    Article  CAS  Google Scholar 

  • Hou YC, Lai CH (2014) Rapid responses of high-dose combined therapy of escitalopram and aripiprazole in a case of severe obsessive compulsive disorder with delusion. J Neuropsychiatry Clin Neurosci 26(2):E44–E45

    Article  Google Scholar 

  • Lee J, Kim BH, Kim E, Howes OD, Cho KIK, Yoon YB (2018) Kwon JS (2018) Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [11 C] DASB PET study. Hum Psychopharmacol 33(1):1–2. https://doi.org/10.1002/hup.2642

    Article  CAS  Google Scholar 

  • Lochner C, Simmons C, Kidd M, Chamberlain SR, Fineberg NA, van Honk J, Ipser J, Stein DJ (2012) Differential effects of escitalopram challenge on disgust processing in obsessive-compulsive disorder. Behav Brain Res 226(1):274–280

    Article  CAS  Google Scholar 

  • Marie C, Pedard M, Quirié A, Tessier A, Garnier P, Totoson P, Demougeot C (2018) Brain-derived neurotrophic factor secreted by the cerebral endothelium: a new actor of brainfunction? J Cereb Blood Flow Metab. 38(6):935–949

    Article  CAS  Google Scholar 

  • Mori A, Nishioka Y, Yamada M, Nishibata Y, Masuda S, Tomaru U, Honma N, Moriyama T, Ishizu A (2018) Brain-derived neurotrophic factor induces angiogenin secretion and nuclear translocation in human umbilical vein endothelial cells. Pathol Res Pract 214(4):521–526

    Article  CAS  Google Scholar 

  • Nakao T, Okada K, Kanba S (2014) Neurobiological model of obsessive-compulsive disorder: evidence from recent neuropsychological and neuroimaging findings. Psychiatry Clin Neurosci 68(8):587–605

    Article  Google Scholar 

  • Pedrotti Moreira F, Wiener CD, Jansen K, Portela LV, Lara DR, Souza LDM, da Silva RA, Oses JP (2018) Serum GDNF levels and anxiety disorders in a population-based study of young adults. Clin Chim Acta 485:21–25

    Article  CAS  Google Scholar 

  • Pizarro M, Fontenelle LF, Paravidino DC, Yücel M, Miguel EC, de Menezes GB (2014) An updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorder. Expert Opin Pharmacother 15(10):1391–1401

    Article  CAS  Google Scholar 

  • Ruven C, Badea SR, Wong WM, Wu W (2018) Combination treatment with exogenous GDNF and fetal spinal cord cells results in better motoneuron survival and functional recovery after avulsion injury with delayed root reimplantation. J Neuropathol Exp Neurol 77(4):325–343

    Article  CAS  Google Scholar 

  • Stryjer R, Dambinsky Y, Timinsky I, Green T, Kotler M, Weizman A, Spivak B (2013) Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study. Int Clin Psychopharmacol 28(2):96–98

    Article  Google Scholar 

  • Suliman S, Hemmings SM, Seedat S (2013) Brain-derived neurotrophic factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis. Front Integr Neurosci 29(7):55

    Google Scholar 

  • Szechtman H, Sulis W, Eilam D (1998) Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD). Behav Neurosci 112(6):1475–1485

    Article  CAS  Google Scholar 

  • Wang X, Min S, Xie F, Yang J, Li L, Chen J (2018) Glial cell-derived neurotrophic factor alleviates sepsis-induced neuromuscular dysfunction by decreasing the expression of γ- and α7-nicotinic acetylcholine receptors in an experimental rat model of neuromyopathy. Biochem Biophys Res Commun 496(2):260–266

    Article  CAS  Google Scholar 

  • Yan XP, Rao Y (2017) Comparison of the efficacy of escitalopram and paroxetine in the treatment of obsessive-compulsive disorder. Shanghai Med Pharmaceutical J 38(18):22–24

    Google Scholar 

  • Zhao LL (2016) Analysis of the efficacy and adverse reactions of escitalopram and paroxetine in the treatment of obsessive-compulsive disorder. Chin J Pract Nervous Dis 19(17):126–128

    Google Scholar 

Download references

Acknowledgements

The research was funded from Henan science and technology department project (172102310578): Study of diffusion tensor imaging of white matter in patients with obsessive–compulsive disorder.

Author information

Authors and Affiliations

  1. Department of Psychiatry, The First Affiliated Hospital of Zhengzhou University, No. 1 of Jianshe East Road, Erqi District, Zhengzhou, 450052, China

    Hui-Rong Guo, Bai-Ling Huang, Ya-Li Wang, Yan-Yan Zhang, Quan-Gang Ma & Pei-Pei Lv

  2. Basic Medical School, Xinxiang Medical University, No.1 Jinsui Avenue, Hongqi District, XinXiang, 453003, China

    Yu-Ming Ren

Authors
  1. Hui-Rong Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bai-Ling Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ya-Li Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yan-Yan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Quan-Gang Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pei-Pei Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yu-Ming Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

HRG and YMR was responsible for the study design and manuscript writing. BLH, YLW, and YYZ were responsible for the study execution and data collection. QGM and PPL were responsible for data management, data analysis, and interpretation. All the authors read and approved the final manuscript.

Corresponding author

Correspondence to Hui-Rong Guo.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, HR., Huang, BL., Wang, YL. et al. Effect of Escitalopram on Serum GDNF and BDNF Levels and 5-HT Level of Brain Tissue of Obsessive–Compulsive Disorder Rats. Cell Mol Neurobiol 40, 991–997 (2020). https://doi.org/10.1007/s10571-020-00788-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-020-00788-4

Keywords

Search

Navigation